Innovations in Drug Discovery and Development Technologies

USD 950

* Required Fields

USD 950


Be the first to review this product

This Drug Discovery TechVision Opportunity Engine (TOE) provides insights across new technologies enabling drug discovery and development. The service encompasses recent advances in nutrient sensing, microfluidic assays, controlled drug delivery, nanosensing, DNA library screening, biosimilars, and breakthrough treatment platforms. Additionally, this TOE summarizes technology trends and innovations related to virtual screening methods for drug discovery applications.

The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders.

The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Nutrient sensing, microfluidics, epilepsy, silicon-based module, monitored drug delivery, nanosensors, DNA-encoded libraries, drug discovery breast cancer, Gorlin Syndrome, patidegib, topical therapy, hedgehog inhibitor, nevoid basal cell carcinoma, virtual screening

Table of Contents

Innovations in Drug Discovery and Development TechnologiesRecent Innovations in Drug Discovery and TherapeuticsUnlocking the Therapeutic Potential of Nutrient Sensing via the mTOR PathwaySpeeding up Drug Discovery Assays by Enhanced Microfluidics TechnologyMiniaturized Silicon-based Module for Controlled and Monitored Drug DeliveryIn-cell Nanosensors to Measure Lipids in the Development of New TherapiesUse of DNA-encoded Libraries for Drug DiscoveryHerceptin Biosimilar Approved by US FDABreakthrough Therapy for Gorlin SyndromeDrug DiscoveryTechnology Focus and TrendsTechnology Focus and TrendsThree Start-up Companies to WatchIndustry Interactions




Related Research

Release Date : 12-Jan-18

Region : Global

Release Date : 05-Jan-18

Region : Global

Release Date : 29-Dec-17

Region : Global

Release Date : 29-Dec-17

Region : Global

Release Date : 22-Dec-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.